203 related articles for article (PubMed ID: 12575984)
1. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway.
Bell RM; Yellon DM
J Am Coll Cardiol; 2003 Feb; 41(3):508-15. PubMed ID: 12575984
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signaling.
Efthymiou CA; Mocanu MM; Yellon DM
J Cardiovasc Pharmacol; 2005 Mar; 45(3):247-52. PubMed ID: 15725950
[TBL] [Abstract][Full Text] [Related]
3. Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS.
Bell RM; Yellon DM
J Mol Cell Cardiol; 2003 Feb; 35(2):185-93. PubMed ID: 12606259
[TBL] [Abstract][Full Text] [Related]
4. Reduction of infarct size by short-term pretreatment with atorvastatin.
Birnbaum Y; Ashitkov T; Uretsky BF; Ballinger S; Motamedi M
Cardiovasc Drugs Ther; 2003 Jan; 17(1):25-30. PubMed ID: 12843684
[TBL] [Abstract][Full Text] [Related]
5. Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?
Mensah K; Mocanu MM; Yellon DM
J Am Coll Cardiol; 2005 Apr; 45(8):1287-91. PubMed ID: 15837263
[TBL] [Abstract][Full Text] [Related]
6. Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin.
Birnbaum Y; Lin Y; Ye Y; Martinez JD; Huang MH; Lui CY; Perez-Polo JR; Uretsky BF
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2891-7. PubMed ID: 17277020
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
[TBL] [Abstract][Full Text] [Related]
8. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway.
Tsang A; Hausenloy DJ; Mocanu MM; Yellon DM
Circ Res; 2004 Aug; 95(3):230-2. PubMed ID: 15242972
[TBL] [Abstract][Full Text] [Related]
9. Loss of ErbB2-PI3K/Akt signaling prevents zinc pyrithione-induced cardioprotection during ischemia/reperfusion.
Thokala S; Inapurapu S; Bodiga VL; Vemuri PK; Bodiga S
Biomed Pharmacother; 2017 Apr; 88():309-324. PubMed ID: 28119233
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice.
Laufs U; Gertz K; Huang P; Nickenig G; Böhm M; Dirnagl U; Endres M
Stroke; 2000 Oct; 31(10):2442-9. PubMed ID: 11022078
[TBL] [Abstract][Full Text] [Related]
11. The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin.
Ye Y; Martinez JD; Perez-Polo RJ; Lin Y; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H343-51. PubMed ID: 18469150
[TBL] [Abstract][Full Text] [Related]
12. Effects of acute and chronic atorvastatin on cardioprotection of ischemic postconditioning in isolated rat hearts.
Fan Y; Yang S; Cao Y; Huang Y
Cardiovasc Ther; 2013 Aug; 31(4):187-92. PubMed ID: 22954178
[TBL] [Abstract][Full Text] [Related]
13. Effect of atorvastatin on expression of IL-10 and TNF-alpha mRNA in myocardial ischemia-reperfusion injury in rats.
Sun YM; Tian Y; Li X; Liu YY; Wang LF; Li J; Li ZQ; Pan W
Biochem Biophys Res Commun; 2009 May; 382(2):336-40. PubMed ID: 19275881
[TBL] [Abstract][Full Text] [Related]
14. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin protects against ischemia-reperfusion injury in fructose-induced insulin resistant rats.
Prakash P; Khanna V; Singh V; Jyoti A; Jain M; Keshari RS; Barthwal MK; Dikshit M
Cardiovasc Drugs Ther; 2011 Aug; 25(4):285-97. PubMed ID: 21671014
[TBL] [Abstract][Full Text] [Related]
16. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling.
Jonassen AK; Sack MN; Mjøs OD; Yellon DM
Circ Res; 2001 Dec; 89(12):1191-8. PubMed ID: 11739285
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway.
Wolfrum S; Dendorfer A; Schutt M; Weidtmann B; Heep A; Tempel K; Klein HH; Dominiak P; Richardt G
J Cardiovasc Pharmacol; 2004 Sep; 44(3):348-55. PubMed ID: 15475833
[TBL] [Abstract][Full Text] [Related]
19. Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway.
Nakata S; Tsutsui M; Shimokawa H; Yamashita T; Tanimoto A; Tasaki H; Ozumi K; Sabanai K; Morishita T; Suda O; Hirano H; Sasaguri Y; Nakashima Y; Yanagihara N
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):92-8. PubMed ID: 17082483
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes.
Schwartz GG; Ganz P; Waters D; Arikian S
Am J Cardiol; 2003 Nov; 92(9):1109-12. PubMed ID: 14583367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
